The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 16, 2016
Filed:
Sep. 04, 2012
Carey V. Campbell, Flagstaff, AZ (US);
Robert L. Cleek, Flagstaff, AZ (US);
Daniel L. Crandall, Flagstaff, AZ (US);
James F. Davidson, Flagstaff, AZ (US);
Paul D. Drumheller, Flagstaff, AZ (US);
Cody L. Hartman, Flagstaff, AZ (US);
Theresa A. Holland, Flagstaff, AZ (US);
Thane L. Kranzler, Flagstaff, AZ (US);
Mei LI, Flagstaff, AZ (US);
Gregory Lostracco, Flagstaff, AZ (US);
Bruce M. Steinhaus, Flagstaff, AZ (US);
Benjamin M. Trapp, Flagstaff, AZ (US);
Thomas G. Triebes, Flagstaff, AZ (US);
Carey V. Campbell, Flagstaff, AZ (US);
Robert L. Cleek, Flagstaff, AZ (US);
Daniel L. Crandall, Flagstaff, AZ (US);
James F. Davidson, Flagstaff, AZ (US);
Paul D. Drumheller, Flagstaff, AZ (US);
Cody L. Hartman, Flagstaff, AZ (US);
Theresa A. Holland, Flagstaff, AZ (US);
Thane L. Kranzler, Flagstaff, AZ (US);
Mei Li, Flagstaff, AZ (US);
Gregory LoStracco, Flagstaff, AZ (US);
Bruce M. Steinhaus, Flagstaff, AZ (US);
Benjamin M. Trapp, Flagstaff, AZ (US);
Thomas G. Triebes, Flagstaff, AZ (US);
W. L. Gore & Associates, Inc., Newark, DE (US);
Abstract
The invention is directed to eluting medical devices that enable consistent 'on-demand' delivery of therapeutic agents to a vessel. The medical device of the current invention comprises an expandable member, a hydrophilic coating comprising at least one therapeutic agent about the expandable member or structural layer and an outer sheath with a variably permeable microstructure. The design and methods disclosed herein ensures that therapeutic agent delivery occurs essentially only during expansion of the expandable member, minimizing coating and/or therapeutic agent loss to the bloodstream and providing controlled delivery to the treatment site.